Gibofsky, Allan

Publications

Sort by

Co-Author Network

selected publications

Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries. Rheumatology and therapy. 2024 Academic Article GET IT
An online survey among US patients with immune-mediated conditions: Attitudes about biosimilars. Journal of managed care & specialty pharmacy. 2023 Academic Article GET IT
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary. Clinical pharmacology and therapeutics. 2022 Review GET IT
Times cited: 12
Biosimilars for immune-mediated inflammatory diseases: a managed care perspective. The American journal of managed care. 2022 Academic Article GET IT
Times cited: 2
Overview of biosimilars for immune-mediated inflammatory diseases: summary of current evidence. The American journal of managed care. 2022 Academic Article GET IT
Times cited: 2
Provider and patient knowledge gaps on biosimilars: insights from surveys. The American journal of managed care. 2022 Academic Article GET IT
Times cited: 2
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis. Osteoarthritis and cartilage. 2021 Academic Article GET IT
Times cited: 18
US rheumatologists' beliefs and knowledge about biosimilars: a survey. Rheumatology (Oxford, England). 2021 Academic Article GET IT
Times cited: 36
Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey. RMD open. 2020 Academic Article GET IT
Times cited: 32
Lorecivivint, a Novel Intraarticular CDC-like Kinase 2 and Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial. Arthritis & rheumatology (Hoboken, N.J.). 2020 Academic Article GET IT
Times cited: 121
Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2020 Academic Article GET IT
Times cited: 4
Geographical variations in COVID-19 perceptions and patient management: a national survey of rheumatologists. Seminars in arthritis and rheumatism. 2020 Academic Article GET IT
Times cited: 12
Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis. The Journal of rheumatology. 2019 Academic Article GET IT
Times cited: 5
A better look at rheumatoid arthritis: Using imaging to improve patient outcomes. Seminars in arthritis and rheumatism. 2018 Academic Article GET IT
Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys. Health and quality of life outcomes. 2018 Academic Article GET IT
Times cited: 34
Short-term costs associated with non-medical switching in autoimmune conditions. Clinical and experimental rheumatology. 2018 Academic Article GET IT
Times cited: 7
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. Clinical rheumatology. 2018 Academic Article GET IT
Times cited: 9
Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis. Arthritis care & research. 2018 Academic Article GET IT
Times cited: 34
Effects of non-medical switching on outcomes among patients prescribed tumor necrosis factor inhibitors. Current medical research and opinion. 2017 Academic Article GET IT
Times cited: 10
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. Osteoarthritis and cartilage. 2017 Academic Article GET IT
Times cited: 52
Sex differences in gout characteristics: tailoring care for women and men. BMC musculoskeletal disorders. 2017 Academic Article GET IT
Times cited: 55
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trial. Clinical rheumatology. 2017 Academic Article GET IT
Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study. Current medical research and opinion. 2015 Academic Article GET IT
Times cited: 15
Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone. Scandinavian journal of rheumatology. 2015 Academic Article GET IT
Times cited: 13
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study. Postgraduate medicine. 2015 Academic Article GET IT
Times cited: 6
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2). Clinical and experimental rheumatology. 2015 Academic Article GET IT
Times cited: 4
The rheumatoid arthritis treat-to-target trial: a cluster randomized trial within the Corrona rheumatology network. BMC musculoskeletal disorders. 2014 Academic Article GET IT
Times cited: 12
Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study. Current medical research and opinion. 2014 Academic Article GET IT
Times cited: 23
Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity. Clinical rheumatology. 2014 Information Resource GET IT
Times cited: 15
Current therapeutic agents and treatment paradigms for the management of rheumatoid arthritis. The American journal of managed care. 2014 Information Resource GET IT
Times cited: 13
Epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: A Synopsis. The American journal of managed care. 2014 Academic Article GET IT
Times cited: 112
Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study. Postgraduate medicine. 2013 Academic Article GET IT
Times cited: 21
Delayed-release prednisone - a new approach to an old therapy. Expert opinion on pharmacotherapy. 2013 Information Resource GET IT
Times cited: 11
The times they are a changin'. Rheumatology (Oxford, England). 2013 Editorial Article GET IT
Comparative effectiveness of current treatments for rheumatoid arthritis. The American journal of managed care. 2012 Academic Article GET IT
Times cited: 15
Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. The American journal of managed care. 2012 Academic Article GET IT
Times cited: 261
A phase 2 study evaluating the efficacy and safety of a novel, proprietary, nano-formulated, lower dose oral diclofenac. Pain medicine (Malden, Mass.). 2012 Academic Article GET IT
Times cited: 19
Need to develop new nonsteroidal anti-inflammatory drug formulations. Clinical therapeutics. 2012 Information Resource GET IT
Times cited: 32
A comparative effectiveness study of adalimumab, etanercept and infliximab in biologically naive and switched rheumatoid arthritis patients: results from the US CORRONA registry. Annals of the rheumatic diseases. 2012 Academic Article GET IT
Times cited: 113
The pharmacokinetic parameters of a single dose of a novel nano-formulated, lower-dose oral diclofenac. Postgraduate medicine. 2012 Academic Article GET IT
Times cited: 20
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. Annals of the rheumatic diseases. 2011 Academic Article GET IT
Times cited: 81
Persistence with anti-tumor necrosis factor therapies in patients with rheumatoid arthritis: observations from the RADIUS registry. The Journal of rheumatology. 2011 Academic Article GET IT
Times cited: 67
Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?. Current opinion in rheumatology. 2011 Information Resource GET IT
Times cited: 21
Musculoskeletal manifestations of thyroid disease. Rheumatic diseases clinics of North America. 2010 Information Resource GET IT
Times cited: 26
Rheumatoid arthritis disease-modifying antirheumatic drug intervention and utilization study: safety and etanercept utilization analyses from the RADIUS 1 and RADIUS 2 registries. The Journal of rheumatology. 2010 Academic Article GET IT
Times cited: 14
Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes. Annals of the rheumatic diseases. 2010 Editorial Article GET IT
Times cited: 14
Pay for performance in rheumatology: will we get the carrot or the stick?. Arthritis and rheumatism. 2008 Editorial Article GET IT
Times cited: 2
Chronic pain of osteoarthritis: considerations for selecting an extended-release opioid analgesic. American journal of therapeutics. 2008 Information Resource GET IT
Times cited: 15
The role of drug and disease registries in rheumatic disease epidemiology. Current opinion in rheumatology. 2008 Information Resource GET IT
Times cited: 25
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. Current rheumatology reports. 2008 Information Resource GET IT
Times cited: 16
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. Current pain and headache reports. 2007 Information Resource GET IT
Times cited: 6
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study. Clinical therapeutics. 2007 Academic Article GET IT
Times cited: 10
Combination therapy for rheumatoid arthritis in the era of biologicals. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2006 Academic Article GET IT
Times cited: 22
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry. Current medical research and opinion. 2006 Academic Article GET IT
Times cited: 59
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study. Current medical research and opinion. 2006 Academic Article GET IT
Times cited: 43
Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritis. Annals of the rheumatic diseases. 2004 Academic Article GET IT
Times cited: 160
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial. Arthritis and rheumatism. 2003 Academic Article GET IT
Times cited: 50
If I am not for myself, who will be for me?. Arthritis and rheumatism. 2003 Conference Paper GET IT
Times cited: 2
Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis and rheumatism. 2002 Editorial Article GET IT
Times cited: 93
American College of Rheumatology. Journal of the Medical Association of Georgia. 2002 Academic Article GET IT
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice. The Journal of rheumatology. 2000 Editorial Article GET IT
Times cited: 47
A diagnostic approach to musculoskeletal pain. Clinical cornerstone. 1999 Academic Article GET IT
Times cited: 2
Rheumatic fever and poststreptococcal reactive arthritis. Current opinion in rheumatology. 1995 Information Resource GET IT
Times cited: 21
Marriage, social support, and adjustment to rheumatic disease. Bulletin on the rheumatic diseases. 1995 Information Resource GET IT
Times cited: 23
Scleroderma in women with silicone breast implants: comment on the article by Sánchez-Guerrero et al. Arthritis and rheumatism. 1995 Letter GET IT
Times cited: 6
Risk management in endoscopic practice. Gastrointestinal endoscopy clinics of North America. 1995 Review GET IT
Times cited: 1
Medicare fraud regulations and the implications for joint ventures: are we working at cross purposes?. Legal medicine. 1995 Academic Article GET IT
Breast implants and connective-tissue diseases. The New England journal of medicine. 1994 Letter GET IT
Times cited: 10
Breast implants and connective-tissue diseases. The New England journal of medicine. 1994 Letter GET IT
Silicone breast implants and connective tissue disease. The Journal of rheumatology. 1994 Letter GET IT
Times cited: 3
Systemic lupus erythematosus presenting as a non-O:1 Vibrio cholerae abscess. 1994 GET IT
Times cited: 5
The developing application of antitrust laws to hospital mergers. The Journal of legal medicine. 1994 Academic Article GET IT
Times cited: 1
Silicone gel filled breast implants and connective tissue disease: an overview. The Journal of rheumatology. 1994 Review GET IT
Times cited: 62
Immunological Reactions to Silicone Implants: Risk and Management. Clinical Immunotherapeutics. 1994 Article GET IT
The Americans with Disabilities Act of 1990--changes in existing protection and impact on the private health services provider. Legal medicine. 1993 Academic Article GET IT
The role of professional education in improving quality of life. Arthritis care and research : the official journal of the Arthritis Health Professions Association. 1992 Editorial Article GET IT
Assessing the impact of self-efficacy beliefs on adaptation to rheumatoid arthritis. Arthritis care and research : the official journal of the Arthritis Health Professions Association. 1991 Academic Article GET IT
The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. The Journal of rheumatology. Supplement. 1991 Information Resource GET IT
Times cited: 59
Social support as a double-edged sword: the relation of positive and problematic support to depression among rheumatoid arthritis patients. Social science & medicine. 1991 Academic Article GET IT
Times cited: 312
Yearbook of health care management 1991. Journal of Legal Medicine. 1991 Article GET IT
Legal implications of therapeutic substitution. Drug Therapy. 1989 Article
Rheumatic fever. Current opinion in rheumatology. 1989 Information Resource GET IT
Times cited: 3
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. The Journal of clinical investigation. 1989 Academic Article GET IT
Times cited: 157
Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity. Current topics in microbiology and immunology. 1989 Information Resource GET IT
Times cited: 49
Immunological aspects of acute rheumatic fever. Bailliere's Clinical Immunology and Allergy. 1987 Article
Genetics of the Hajdu-Cheney syndrome. Arthritis and rheumatism. 1987 Letter GET IT
Times cited: 3
Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fc gamma receptor specific. Journal of immunology (Baltimore, Md. : 1950). 1986 Academic Article GET IT
Times cited: 21
Methyldopa and reticuloendothelial function. The New England journal of medicine. 1986 Article GET IT
Times cited: 1
Genetic control of the susceptibility to infection with pathogenic bacteria. Current topics in microbiology and immunology. 1986 Information Resource GET IT
Times cited: 8
Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. Journal of immunology (Baltimore, Md. : 1950). 1984 Academic Article GET IT
Times cited: 76
Immunogenetic and clinical findings in idiopathic pulmonary fibrosis. Association with the B-cell alloantigen HLA-DR2. The American review of respiratory disease. 1983 Academic Article GET IT
Impaired fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults. The Journal of experimental medicine. 1983 Academic Article GET IT
Times cited: 32
Familial systemic lupus erythematosus in males. Arthritis and rheumatism. 1983 Academic Article GET IT
Times cited: 53
Pac-Man phalanx. Arthritis and rheumatism. 1983 Letter GET IT
Times cited: 2
Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis. Annals of internal medicine. 1982 Academic Article GET IT
Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clinical immunology and immunopathology. 1982 Academic Article GET IT
Times cited: 85
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. The Journal of experimental medicine. 1980 Academic Article GET IT
Times cited: 273
Adverse presensitization: detection by utilization of B lymphoblastoid cell panels. Transplantation proceedings. 1979 Academic Article GET IT
Times cited: 1
Chronic Lyme arthritis. Clinical and immunogenetic differentiation from rheumatoid arthritis. Annals of internal medicine. 1979 Academic Article GET IT
Association of HLA-DRw2 with autoimmune thrombocytopenic purpura. The Journal of clinical investigation. 1979 Academic Article GET IT
Times cited: 46
Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. The Journal of experimental medicine. 1978 Academic Article GET IT
Times cited: 148
Expression of Ia-like antigens on cultured human malignant melanoma cell lines. Proceedings of the National Academy of Sciences of the United States of America. 1978 Academic Article GET IT
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis and rheumatism. 1978 Academic Article GET IT
Times cited: 38
The identification of HL-A antigens on fresh and cultured human endothelial cells. Journal of immunology (Baltimore, Md. : 1950). 1975 Academic Article GET IT
Times cited: 17
Medium effects for single ions in acetonitrile and ethanol-water solvents based on reference-electrolyte assumption. Analytical chemistry. 1972 Academic Article GET IT
Times cited: 81

more ...

less ...

Background

education and training

M.D., Cornell University Medical College 73
B.S., Brooklyn College, City University of New York 1969

Contact

full name

Allan Gibofsky

primary email

alg2004@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Allan Gibofsky Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage